Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report January – March 2022

“Earnings capacity up 4 per cent and extended credit agreements at attractive levels”Andreas Morfiadakis, CEO January - March · Revenue for the quarter amounted to SEK 118.7 million (56.2), a year-on-year increase of 111 per cent. · The Group’s net operating income amounted to SEK 59.4 million (25.7), up 131 per cent year-on-year. · Profit from property management for the quarter amounted to SEK 30.2 million (8.4), a year-on-year increase of 260 per cent. · Changes in the value of investment properties amounted to of SEK169.2 million (70.5) and changes in the value of

Invitation to presentation of Isofol's report for the first quarter of 2022

GOTHENBURG, Sweden, May 3, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), will publish the company’s results for the first quarter of 2022 on Thursday, May 12, 2022. On the same day, Isofol invites investors, analysts, and media to an audiocast with a subsequent question and answer session.In conjunction with the publication of the interim report for the first quarter of 2022, Isofol invites investors, analysts, and media to an audiocast on May 12, 2022 at 11:00 a.m. CEST. The presentation will be held by Isofol´s CEO Ulf Jungnelius and CFO Gustaf Albèrt, who will

Ilya Pharma strengthens board with appointments of corporate development specialist Hughes Crameri and Galderma veteran Carson

Uppsala, May 3, 2022: Ilya Pharma (the Company), a clinical stage immunotherapy company today announced the appointments of Dr Melya Hughes Crameri and William (Bill) Carson to the Board of Directors. The appointments come as the company approaches key stages in the development of its portfolio of three first-in-class immunotherapies for skin and mucosal diseases - ILP100-Topical for treatment of surgical wounds in diabetic, pre-diabetic and obese patients especially at risk, ILP100-Topical for diabetic ulcers and ILP100-Oral for patients with immune mediated enterocolitis resulting from

A great start to 2022 with integration ahead of plan

Financial summary for the first quarter                                                                                                                                                                                                                         · Net sales increased by 139.3 percent to EUR 67.3m (28.1). Organic growth excluding currency effects was 27.8 percent (40.2) · Gross profit amounted to EUR 41.3m (14.5) with a gross margin of 61.3 percent (51.5) · Adjusted EBITDA amounted to EUR 8.1m (5.5) with an adjusted EBITDA margin of 12.1 percent (19.7). Adjusted EBITDA,

Invitation to Oneflow’s Q1 presentation on 6 May

Press releaseMay 3, 2022 Oneflow will publish its interim report for the first quarter 2022 on 6 May at 08:00 CET. The report will be presented in a webinar at 10:00 CET the same day. Anders Hamnes, CEO and Founder of Oneflow, and Ilona Prander, CFO of Oneflow, will present the report and answer questions. The presentation will be held in English. To join the conference, please register here: https://oneflow.zoom.us/webinar/register/WN_aiizLaURRyiM48z0quO4sg Report and presentation will be available for download on our website here: https://oneflow.com/ir/investors/financial-

BPC Instruments presented its expansion into new business segments and solid business growth at Sedermeradagen Stockholm

BPC Instruments presented the company’s expansion into new business segments and solid business growth at Sedermeradagen Stockholm on April 25. CEO Dr. Jing Liu attended the event and talked about the company’s current market and expansion to enter new business segments within the biotech field. Furthermore, BPC presented its latest financial figures that show that BPC continues to be a solid, stable, and profitable company with good business growth despite the recent challenges caused by the pandemic.“We have successfully entered the business segment biodegradability analysis of plastics.

Operational Update

3 May 2022 IOG plc Operational Update IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, provides a full operational update ahead of its Annual General Meeting today. Andrew Hockey, CEO of IOG, commented:  "I am pleased to provide an update on the initial weeks of Blythe and Elgood production. As we address early facilities issues and control liquids handling onshore, production is currently stabilising at 55-65 mmscf/d gas and 800-1,000 bbl/d condensate, with steadily improving uptime rates.

Fortum to record pre-tax impairments of approximately EUR 2.1 billion related to its Russian operations

FORTUM CORPORATION INSIDE INFORMATION 3 MAY 2022 AT 9:00 EEST Following Russia’s attack and the war in Ukraine and the consequential geopolitical tensions, uncertainties and risks, Fortum will record pre-tax impairments of approximately EUR 2.1 billion related to the company’s Russian operations in its first quarter 2022 results. The impairments include approximately EUR 0.3 billion related to fixed assets and goodwill for Fortum’s Russia segment and approximately EUR 0.6 billion for fixed assets from Uniper segment’s Russian subsidiary Unipro. These will be recorded as items

HANZA: Interim report January – March 2022

HANZA Holding AB (publ) reports record high growth during the first quarter of 2022, as well as strong order intake from all customer areas. Furthermore, the company has inaugurated a newly built production facility of 12,000 sqm, in Tartu, Estonia, and will expand during the spring with new production areas in Poland, the Czech Republic and China.First quarter 2022 · Net sales increased by 45% to SEK 824 million (567). Adjusted for acquisitions and currency, growth amounted to 28 %. · Operating profit (EBITA) increased by 83% to SEK 41.2 million (22.5), which corresponds to an

Nel ASA: EverWind Fuels has elected Nel to participate in the FEED study for the Point Tupper project

(Oslo, 3. May, 2022) Nel ASA (Nel, OSE:NEL) has been elected as technology provider for EverWind Fuels’ Point Tupper project in in Nova Scotia for a potential 200 MW electrolyser facility. “We are excited to be elected for this important and ambitious project”, says Jon André Løkke, CEO. For additional information see EverWind Fuels’ press release below.  EverWind Fuels to establish a regional green hydrogen hub in Nova Scotia reducing carbon emissions and bringing clean energy jobs to Nova Scotia Production of green hydrogen to begin in 2025 at former NuStar Storage Terminal in

Two new restaurants and one nail salon to open on Drottninggatan

Hufvudstaden is welcoming three new brands to Drottninggatan in Stockholm. Norwegian café concept Backstube, poké bowl restaurant Poh Keh and Nail Democracy will all open in the spring of 2022.Drottninggatan, will during spring, open two new restaurants and one new creative nail salon. Norwegian Backstube, which will open on Drottninggatan 92-94, is a mix of café and bakery where fresh buns and bread are freshly baked and served every day. Next door, at the same address, Poh Keh is opening, offering Hawaiian poké bowls packed with healthy ingredients and made from scratch.     Nail

Wihlborgs introduces pricing on CO2 emissions

In 2022, Wihlborgs is introducing internal pricing on CO\2\e emissions and a threshold for new-build projects. The aim is to increase focus on climate impact for project investments and to favour sustainable choices in supplier chains.The internal price for CO\2\ equivalents (CO\2\e) emissions is being set at SEK 1,000 per tonne and will initially be tested in a number of redevelopment project investment decisions before being evaluated. Moving forward, the aim is to integrate the cost of climate impact in the decision process. “The overall aim is to forge a more distinct connection

Panoro Energy: Notice of Annual General Meeting 2022

Oslo, 3 May 2022 – Panoro Energy ASA, (“Panoro” or the “Company” with OSE Ticker: PEN) today announces that the Annual General Meeting (“AGM”) scheduled for 25 May 2022 will be held at 10am CEST at the Company's offices located at Schjødt law- firm, Ruseløkkveien 14, Oslo, Norway. The formal notice of the AGM is attached to this release and can also be downloaded from our website at www.panoroenergy.com. Proposed appointment of a new Director to the Board In addition to recommending the re-election of the current Board for a period of one year, the Nomination Committee proposes a

Interim Report January-March 2022

Stable quarter with high volumes in Contracting Sweden’s operations First quarter · Consolidated net sales increased by 7.1 percent to SEK 95.3 million (88.9). · Operating profit (EBIT) increased marginally to SEK 8.8 million (8.7). · Profit per share before and after dilution amounted to SEK 0.25 (0.26).  Significant events in the first quarter  · In January, Railcare signed a new framework agreement with the Swedish Transport Administration relating to contracting work in Sweden. The new agreement includes opportunities for the use of the MPV, the battery-powered

Aker Solutions ASA: First-Quarter Results 2022

May 3, 2022 – Aker Solutions' revenue and margins increased in the first quarter of 2022. The company delivered another quarter of solid performance and continued to demonstrate that it remains on track with its transformation and growth targets. Projects globally continued to progress well, tendering activity continues to be very high, and the market outlook remains positive.1Q 2022 Financial Highlights (excluding special items)  · Revenue NOK 8.3 billion  · EBITDA NOK 583 million   · EBITDA margin 7.0 percent  · Earnings per share NOK 0.39  · Net cash position NOK 3.3

Interim report of Atria Plc, 1 January–31 March 2022

Atria Plc, Interim report, 3 May 2022, 8.00 amInterim report of Atria Plc, 1 January–31 March 2022Atria's net sales grew in all business areas – EBIT was brought down by increased costsJanuary–March 2022- Consolidated net sales totalled EUR 374.8 million (EUR 361.3 million).- Consolidated EBIT was EUR 2.3 million (EUR 6.6 million), or 0.6 per cent (1.8%) of net sales.- Consolidated net sales grew, which was due to increased sales to feed and Foodservice customers.- Sales prices increased slightly in the retail and Foodservice channels.- Increased costs weakened EBIT.- In

Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May

Oslo, Norway, 3 May 2022 - Targovax ASA (OSE: TRVX) will announce its first quarter 2022 results on Thursday 12 May 2022. An online presentation by Targovax's management to investors, analysts and the press will take place at 10:00 am CET.The results report and the presentation will be available at www.targovax.com  in the Investors section from 07:00 am CET. Presentation There will be a virtual presentation of the results with a live webcast 12 May at 10.00 am CET. You can join the webcast here 

Altris to Manufacture Ground-breaking Cathode Material in Sandviken, Sweden

Sodium-ion battery cathode producer Altris AB has today signed a deal with AB Sandvik Materials Technology to house the company’s first industrial scale manufacturing facility in Sandviken. The new facility, called ‘Ferrum’, will have the annual capacity to produce 2000 metric tonnes of Altris’ ground-breaking cathode material Fennac – enabling 1GWh of sustainable sodium-ion batteries to enter the market each year.The site for Ferrum was selected based on the impressive infrastructure and onsite expertise that is available, which will facilitate the installation and ongoing support needs

ABS Awards AIP to HHI Group’s Green Hydrogen Production Platform and Carbon Dioxide Injection Platform Design

Pictured at the AIP signing are John McDonald, ABS Executive Vice President and Chief Operating Officer, and S.Y. Park, Hyundai Heavy Industries Senior Executive Vice President, Chief Operating Officer and Head of Group Ship/Offshore Marketing Division. Key Step Forward in Pioneering Decarbonization JDP(HOUSTON) A pioneering joint development project (JDP) to advance carbon-reduction technologies between ABS and Hyundai Heavy Industries Group (HHI Group) has taken a significant step forward by securing Approval in Principle (AIP). ABS has awarded AIP to the carbon dioxide injection

Nordea Bank Abp: Repurchase of own shares on 02.05.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares02.05.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 02.05.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XSTO 256,192 9.44 2,419,086.25XHEL 258,471 9.44 2,439,164.98CEUX 215,947 9.44 2,038,704.88AQEU 17,070 9.47 161,669.92

Notification of Executive’s transaction with Vestas shares

Vestas Wind Systems A/S, Aarhus, 2 May 2022Company announcement no. 11/2022 In accordance with Article 19 (3) of the EU Market Abuse Regulation, Vestas Wind Systems A/S is required to disclose information regarding trading in Vestas Wind Systems A/S shares and securities by Executives and persons closely associated with an Executive. The statement is based on a report which Vestas Wind Systems A/S has received from one of the Executives, see appendix. Contact detailsVestas Wind Systems A/S, Denmark Mathias Dalsten, Vice PresidentInvestor RelationsTel: +45 2829 5383

CS MEDICA A/S: CS MEDICA revises financial targets

CS MEDICA (”CS MEDICA” or the ”Company”) announces today that due to delays from the COVID-19 lockdown, the Company’s revenue goal for the coming three financial years has been revised. The revenue goal for the year 2021/2022 is reduced to DKK 12 million from previously DKK 50 million. The revenue goal for the following financial year, 2022/2023, will be adjusted to DKK 65 million from previously DKK 150 million. The revenue goal of DKK 150 million is sought to be accomplished in the financial year 2023/2024.Due to significant delays in the different business areas of CS MEDICA caused by

The Board of Directors of Prostatype Genomics AB proposes for the Annual General Meeting to authorize the Board  to decide on a rights issue to intensify the launch of the Prostatype®  test

The Board of Directors of Prostatype Genomics AB (”Prostatype Genomics” or “the Company”) has today, the 2[nd] of May 2022, decided to propose that the upcoming Annual General Meeting resolves to authorize the Board to decide on a rights issue of units of initially approx. SEK 22.5 million before issue costs, followed by an additional approx. SEK 22.5 million referring to attached warrants (”the Rights Issue”). The general public is also suggested to have the possibility to subscribe in the Rights Issue. The initial part of the Rights Issue is to 100 percent covered by pre-subscription and

There are no items matching the current filter
There are no more items matching the current filter
Back to top